SI3501534T1 - Cepivni sestavki, ki obsegajo mutiran vezavni protein faktorja h - Google Patents

Cepivni sestavki, ki obsegajo mutiran vezavni protein faktorja h

Info

Publication number
SI3501534T1
SI3501534T1 SI200932190T SI200932190T SI3501534T1 SI 3501534 T1 SI3501534 T1 SI 3501534T1 SI 200932190 T SI200932190 T SI 200932190T SI 200932190 T SI200932190 T SI 200932190T SI 3501534 T1 SI3501534 T1 SI 3501534T1
Authority
SI
Slovenia
Prior art keywords
binding protein
vaccine compositions
mutated factor
mutated
factor
Prior art date
Application number
SI200932190T
Other languages
English (en)
Inventor
Rachel Exley
Christoph Tang
Susan M. Lea
Original Assignee
Ip2Ipo Innovations Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ip2Ipo Innovations Limited filed Critical Ip2Ipo Innovations Limited
Publication of SI3501534T1 publication Critical patent/SI3501534T1/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/095Neisseria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SI200932190T 2008-10-25 2009-10-26 Cepivni sestavki, ki obsegajo mutiran vezavni protein faktorja h SI3501534T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0819633.9A GB0819633D0 (en) 2008-10-25 2008-10-25 Composition
EP18209661.0A EP3501534B1 (en) 2008-10-25 2009-10-26 Vaccine compositions comprising a mutated factor h binding protein

Publications (1)

Publication Number Publication Date
SI3501534T1 true SI3501534T1 (sl) 2024-03-29

Family

ID=40133849

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200932190T SI3501534T1 (sl) 2008-10-25 2009-10-26 Cepivni sestavki, ki obsegajo mutiran vezavni protein faktorja h

Country Status (23)

Country Link
US (1) US20120052092A1 (sl)
EP (2) EP2355845B1 (sl)
JP (2) JP5676458B2 (sl)
KR (3) KR20110092282A (sl)
CN (2) CN105412920A (sl)
AU (1) AU2009306114B2 (sl)
BR (1) BRPI0919926A2 (sl)
CA (1) CA2741619A1 (sl)
CO (1) CO6382140A2 (sl)
DK (1) DK3501534T3 (sl)
ES (1) ES2970878T3 (sl)
FI (1) FI3501534T3 (sl)
GB (1) GB0819633D0 (sl)
HR (1) HRP20240226T1 (sl)
HU (1) HUE065348T2 (sl)
LT (1) LT3501534T (sl)
MX (1) MX2011004322A (sl)
NZ (2) NZ592444A (sl)
PL (1) PL3501534T3 (sl)
PT (1) PT3501534T (sl)
RU (1) RU2559528C2 (sl)
SI (1) SI3501534T1 (sl)
WO (1) WO2010046715A1 (sl)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9910089A (pt) 1998-05-01 2004-06-08 Chiron Corp Composições e antìgenos de neisseria meningitidis
EP2270174A1 (en) 1999-05-19 2011-01-05 Novartis Vaccines and Diagnostics S.r.l. Combination neisserial compositions
EP2275552B1 (en) 1999-10-29 2015-09-09 GlaxoSmithKline Biologicals SA Neisserial antigenic peptides
PT2270030E (pt) 2000-02-28 2012-07-24 Novartis Vaccines & Diagnostic Expressão heteróloga de proteínas de neisseria
GB0118249D0 (en) 2001-07-26 2001-09-19 Chiron Spa Histidine vaccines
GB0121591D0 (en) 2001-09-06 2001-10-24 Chiron Spa Hybrid and tandem expression of neisserial proteins
WO2004032958A1 (en) 2002-10-11 2004-04-22 Chiron Srl Polypeptide-vaccines for broad protection against hypervirulent meningococcal lineages
GB0227346D0 (en) 2002-11-22 2002-12-31 Chiron Spa 741
GB0408977D0 (en) 2004-04-22 2004-05-26 Chiron Srl Immunising against meningococcal serogroup Y using proteins
GB0524066D0 (en) 2005-11-25 2006-01-04 Chiron Srl 741 ii
NZ587382A (en) 2008-02-21 2012-01-12 Novartis Ag Meningococcal fhbp polypeptides
EP2631245A1 (en) 2008-03-10 2013-08-28 Children's Hospital & Research Center at Oakland Chimeric factor H binding proteins (fHBP) containing a heterologous B domain and methods of use
NZ595234A (en) 2009-03-24 2013-12-20 Novartis Ag Adjuvanting meningococcal factor h binding protein
WO2010127172A2 (en) 2009-04-30 2010-11-04 Children's Hospital & Research Center At Oakland Chimeric factor h binding proteins (fhbp) and methods of use
BR112012010531A2 (pt) * 2009-10-27 2019-09-24 Novartis Ag "polipeptídeos de modificação meningocócica fhbp"
CN102869377A (zh) * 2010-03-10 2013-01-09 葛兰素史密丝克莱恩生物有限公司 免疫原性组合物
ES2910199T3 (es) * 2010-03-30 2022-05-11 Childrens Hospital & Res Center At Oakland Proteínas de unión al factor H (fHbp) con propiedades alteradas y métodos de uso de las mismas
EP2585106A1 (en) 2010-06-25 2013-05-01 Novartis AG Combinations of meningococcal factor h binding proteins
EP3299467B1 (en) 2012-02-02 2021-08-11 GlaxoSmithKline Biologicals SA Promoters for increased protein expression in meningococcus
NZ630133A (en) 2012-06-14 2016-10-28 Novartis Ag Vaccines for serogroup x meningococcus
EP2877492A1 (en) 2012-07-27 2015-06-03 Institut National de la Santé et de la Recherche Médicale (INSERM) Cd147 as receptor for pilus-mediated adhesion of meningococci to vascular endothelia
WO2014140562A1 (en) * 2013-03-14 2014-09-18 Isis Innovation Limited Immunogenic composition to neisseria
SG11201600334SA (en) 2013-08-02 2016-02-26 Children S Hospital & Res Ct Oakland Non-naturally occurring factor h binding proteins (fhbp) and methods of use thereof
BR112016019735A2 (pt) 2014-02-28 2017-10-17 Glaxosmithkline Biologicals Sa fhbp, polipeptídeo, plasmídeo ou outro ácido nucleico, célula hospedeira, vesículas de membrana, e, composição imunogênica
WO2016014719A1 (en) 2014-07-23 2016-01-28 Children's Hospital & Research Center Oakland Factor h binding protein variants and methods of use thereof
CN107074939B (zh) * 2014-08-20 2021-09-07 桑昆血液供给基金会 H因子增强抗体及其用途
EP3607967A1 (en) 2018-08-09 2020-02-12 GlaxoSmithKline Biologicals S.A. Modified meningococcal fhbp polypeptides
AU2020309556A1 (en) * 2019-07-08 2022-03-03 Crapaud Bio, Inc. Methods of making and using lipooligosaccharide compositions and vaccines
AR122286A1 (es) 2019-07-17 2022-08-31 Gemini Therapeutics Sub Inc Anticuerpos potenciadores del factor h y usos de estos
IL305313A (en) 2021-02-19 2023-10-01 Sanofi Pasteur Recombinant meningococcal B vaccine
WO2024030931A1 (en) 2022-08-03 2024-02-08 Sanofi Pasteur Inc. Adjuvanted immunogenic composition against neisseria meningitidis b

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4786592A (en) * 1986-06-18 1988-11-22 Scripps Clinic And Research Foundation Neisseria gonorrhoeae lectin useful as a vaccine and diagnostic marker and means for producing this lectin
US5476784A (en) * 1993-04-06 1995-12-19 Rice; Peter A. Gonococcal anti-idiotypic antibodies and methods and compositions using them
GB0220194D0 (en) * 2002-08-30 2002-10-09 Chiron Spa Improved vesicles
EP1618185A4 (en) * 2003-04-16 2009-05-27 Wyeth Corp NEW IMMUNOLOGICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF MENINGOCOCCOULAR DISEASE
NZ555937A (en) * 2005-01-27 2009-05-31 Childrens Hosp & Res Ct Oak GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by Neisseria meningitidis
GB0524066D0 (en) * 2005-11-25 2006-01-04 Chiron Srl 741 ii
CN101479293A (zh) * 2006-06-29 2009-07-08 诺华有限公司 脑膜炎奈瑟球菌多肽
WO2011024072A2 (en) * 2009-08-27 2011-03-03 Novartis Ag Hybrid polypeptides including meningococcal fhbp sequences
ES2910199T3 (es) * 2010-03-30 2022-05-11 Childrens Hospital & Res Center At Oakland Proteínas de unión al factor H (fHbp) con propiedades alteradas y métodos de uso de las mismas

Also Published As

Publication number Publication date
CN105412920A (zh) 2016-03-23
AU2009306114B2 (en) 2015-10-01
ES2970878T3 (es) 2024-05-31
PT3501534T (pt) 2024-02-07
CN102245202A (zh) 2011-11-16
CA2741619A1 (en) 2010-04-29
NZ592444A (en) 2012-11-30
BRPI0919926A2 (pt) 2016-02-16
WO2010046715A1 (en) 2010-04-29
NZ601538A (en) 2014-01-31
JP5676458B2 (ja) 2015-02-25
MX2011004322A (es) 2011-06-16
DK3501534T3 (da) 2024-02-05
EP3501534B1 (en) 2023-11-29
AU2009306114A1 (en) 2010-04-29
EP2355845B1 (en) 2018-12-05
FI3501534T3 (fi) 2024-02-09
KR20170000390A (ko) 2017-01-02
EP3501534A1 (en) 2019-06-26
US20120052092A1 (en) 2012-03-01
CO6382140A2 (es) 2012-02-15
PL3501534T3 (pl) 2024-04-02
RU2559528C2 (ru) 2015-08-10
KR20190011836A (ko) 2019-02-07
LT3501534T (lt) 2024-03-12
EP2355845A1 (en) 2011-08-17
KR20110092282A (ko) 2011-08-17
GB0819633D0 (en) 2008-12-03
JP2012506411A (ja) 2012-03-15
RU2011120706A (ru) 2012-11-27
JP2015063558A (ja) 2015-04-09
HUE065348T2 (hu) 2024-05-28
HRP20240226T1 (hr) 2024-05-10
JP6076326B2 (ja) 2017-02-08

Similar Documents

Publication Publication Date Title
HUE065348T2 (hu) Egy mutált H-faktor-kötõ fehérjét tartalmazó vakcinakészítmények
HK1210015A1 (en) Adjuvanting meningococcal factor binding protein
GB2461546B (en) Antigen binding polypeptides
ZA201104397B (en) Myostatin binding proteins
GB2449354B (en) Binding protein
IL219202A0 (en) Il-1 binding proteins
IL214341A0 (en) Il-1 binding proteins
HK1202806A1 (en) Il-17 binding proteins il-17
ZA201004133B (en) Antigen binding proteins
EP2360172A4 (en) BIPODAL PEPTIDE BINDER
IL209585A0 (en) Angiopoietin derived peptides
PL2249996T3 (pl) Zszywacz
GB0816976D0 (en) Protein
EP2252326A4 (en) VACCINE COMPOSITIONS
AU326165S (en) Stapler
GB0801122D0 (en) Vaccine composition
PL118319U1 (pl) Zszywacz
GB0818627D0 (en) Protein
GB0804680D0 (en) Binding polypeptides
GB0714346D0 (en) binding peptides
GB0702363D0 (en) Vaccine composition
IL210002A0 (en) Antigen binding polypeptides
GB0817077D0 (en) Proteins
GB0904217D0 (en) Binding polypeptides
IL206541A0 (en) Novel protein